Duke Doctors on Both Sides of the Trasylol Debate
Pharmalot notes that doctors at Duke University Medical Center figure prominently on both sides of the debate over Trasylol’s safety.
On one side is Dr. Peter Smith, Duke’s chief of thoracic and cardiovascular surgery. Smith is a consultant for Bayer AG, the maker of Trasylol. Last September, Smith appeared before an FDA advisory committee and testified that the anti-bleeding drug is safe and effective.
On the other side of the issue are 11 doctors from Duke’s anesthesiology and surgery departments who co-authored the recent study that concluded patients given Trasylol had a 27 percent greater chance of dying than those given a comparable drug.
If you or a loved one suffered complications after taking Trasylol contact Carey & Danis. We can help. Carey & Danis is a national law firm that represents individuals injured by America's largest corporations.
For more information, fill out our online contact form or call Carey & Danis toll-free at 800-721-2519.
